Saturday 17 October 2026
Export ZEPP’s income statement to Excel — free account
Zepp Health Corporation Sponsored ADR
ZEPP Technology Consumer Electronics
Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024. In the quarter to June 2026, revenue grew 6.93%, EPS fell 46.9%, free cash flow fell 103.7% and total debt rose 26.4%, each against the same quarter a year earlier.
3.04
0.16
−5.00%
Follow ZEPP
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 7 | 3 | 3 | 3 | 2 | 6 | 3 | 5 |
P/E ratio |
0.00 | 0.13 | 11.54 | 8.97 | 21.94 | 19.80 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 3.66 | 3.34 | 2.78 | 2.11 | 1.22 | 1.12 | 0.35 | 1.01 |
P/S ratio |
0.00 | 0.00 | 0.98 | 0.88 | 0.75 | 1.32 | 0.16 | 0.25 | 0.23 | 1.65 |
Altman Z″-Score (non-manufacturers) |
1.52 | 3.19 | 5.36 | 4.76 | 3.99 | 3.68 | 2.76 | 3.19 | 1.24 | 0.31 |
P/FCF ratio |
0.00 | 0.00 | 3.86 | 3.85 | 4.86 | 8.45 | 2.24 | 0.00 | 11.31 | 0.00 |
Beneish M-Score |
— | (2.52) | (2.63) | (1.42) | (2.43) | (2.08) | (1.88) | (3.52) | (2.96) | (2.49) |
P/Operating CF |
0.00 | (0.04) | (37.46) | (52.68) | (52.96) | (92.12) | (6.96) | (6.30) | (1.72) | (16.67) |
P/B ratio |
0.00 | 0.02 | 1.98 | 2.04 | 1.76 | 2.79 | 0.25 | 0.25 | 0.17 | 2.00 |
Price to Tangible BV |
0.00 | 0.02 | 2.06 | 2.12 | 1.90 | 3.00 | 0.27 | 0.26 | 0.18 | 2.24 |
EV/Sales |
0.00 | 0.00 | 0.54 | 0.58 | 0.48 | 1.28 | 0.32 | 0.18 | 0.26 | 1.66 |
EV/EBITDA |
0.00 | 0.00 | 5.42 | 5.59 | 17.61 | 50.49 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 2.03 | 2.42 | 2.69 | 7.09 | 2.63 | 4.55 | 3.20 | (32.02) |
EV/FCF |
0.00 | 0.00 | 2.14 | 2.56 | 3.10 | 8.17 | 4.52 | (15.95) | 12.75 | (36.61) |
Quick Ratio |
1.04 | 1.13 | 1.67 | 1.38 | 1.24 | 1.10 | 1.10 | 1.39 | 0.91 | 0.65 |
Current Ratio |
1.36 | 1.48 | 2.06 | 1.77 | 1.73 | 1.83 | 1.77 | 2.04 | 1.29 | 1.02 |
Net Debt/EBITDA |
(9.52) | (1.86) | (4.19) | (2.74) | (8.38) | (1.76) | (1.93) | 1.05 | (0.13) | (0.09) |
Debt/Assets |
1.25% | 2.61% | 1.20% | 2.15% | 10.36% | 21.00% | 32.03% | 19.15% | 22.15% | 20.40% |
Debt/Equity |
0.40 | 0.17 | 0.02 | 0.04 | 0.22 | 0.44 | 0.63 | 0.35 | 0.46 | 0.54 |
Asset Turnover |
1.26 | 1.70 | 1.52 | 1.37 | 1.20 | 1.05 | 0.70 | 0.50 | 0.31 | 0.47 |
Operating CF/Net income |
(1.42) | 5.17 | 6.24 | 0.75 | 0.69 | (1.69) | 2.73 | (1.37) | 0.32 | 0.64 |
Capex/Depreciation |
(4.79) | (5.75) | (11.10) | (2.67) | (3.12) | (0.97) | (0.17) | 0.40 | 0.05 | (0.04) |
Interest Coverage |
17.73 | 62.95 | 30.36 | 17.98 | 4.00 | 2.09 | (7.20) | (4.51) | (8.51) | (5.13) |
| (9.29%) | 35.79% | 11.07% | 26.46% | 9.02% | 4.92% | (9.84%) | (8.36%) | (25.02%) | (17.15%) | |
| (0.98%) | 3.82% | 4.72% | 13.52% | 4.25% | 2.33% | (4.86%) | (4.43%) | (13.01%) | (7.33%) | |
ROIC |
0.00% | 0.00% | 91.68% | 48.12% | 10.44% | 2.19% | (7.62%) | (5.79%) | (11.44%) | (8.43%) |
Return on Tangible Assets |
(5.13%) | 10.32% | 7.52% | 29.00% | 10.58% | 7.20% | (20.73%) | (18.19%) | (120.03%) | (324.62%) |
Average Days of Receivables |
116.41 | 108.90 | 71.62 | 101.11 | 65.71 | 48.63 | 72.31 | 71.72 | 131.18 | 103.73 |
Research and Development Expense of Revenue |
8.50% | 7.51% | 7.22% | 7.41% | 8.36% | 8.24% | 12.48% | 14.60% | 25.28% | 17.50% |
Selling, General and Administrative Expense of Revenue |
8.38% | 7.76% | 8.52% | 7.41% | 9.64% | 11.15% | 16.81% | 20.21% | 39.06% | 32.10% |
Intangible Assets out of Total Assets |
0.00 | 0.01 | 0.02 | 0.02 | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 |
Share Based Compensation of Revenue |
3.71% | 3.06% | 3.70% | 0.95% | 1.01% | 1.33% | 1.19% | 2.49% | 2.62% | 0.96% |
Graham Net Nets |
0.00 | 16.53 | 0.39 | 0.34 | 0.34 | 0.10 | 0.56 | 0.39 | (0.58) | (0.13) |
Graham Number |
0.00 | 0.00 | 39.03 | 53.30 | 36.19 | 12.88 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(85.71%) | 800.00% | 8.66% | 11.15% | 4.56% | 5.05% | (44.59%) | (34.42%) | (181.15%) | (9.32%) |
Free Cash Flow Yield |
0.00% | 0.00% | 25.90% | 26.00% | 20.58% | 11.83% | 44.71% | (4.56%) | 8.84% | (2.75%) |
Revenue per Share |
67.31 | 74.34 | 40.04 | 54.83 | 63.49 | 62.23 | 39.02 | 23.22 | 11.29 | 16.28 |
Operating CF per Share |
0.75 | 8.65 | 7.77 | 4.04 | 1.55 | (2.31) | (7.42) | 2.80 | (1.51) | (1.62) |
Capex per Share |
(0.50) | (0.78) | (0.76) | (0.43) | (0.84) | (0.50) | (0.09) | 0.20 | 0.02 | (0.01) |
Free Cash Flow per Share |
0.25 | 7.87 | 7.01 | 3.60 | 0.72 | (2.82) | (7.51) | 3.00 | (1.49) | (1.63) |
Cash per Share |
7.02 | 13.91 | 17.57 | 17.18 | 22.69 | 15.27 | 9.49 | 9.58 | 6.91 | 7.10 |
Shareholders Equity per Share |
1.30 | 8.28 | 19.88 | 23.56 | 26.94 | 29.21 | 25.29 | 23.21 | 15.62 | 13.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.30 | 8.28 | 19.88 | 23.56 | 26.94 | 29.21 | 25.29 | 23.21 | 15.62 | 13.49 |
Free Cash Flow |
0.87 | 33.35 | 92.87 | 54.87 | 11.12 | (44.41) | (115.64) | 45.66 | (24.13) | (25.88) |
Working Capital |
33.89 | 64.26 | 213.77 | 274.45 | 312.37 | 279.14 | 187.02 | 161.62 | 56.20 | 6.68 |
Capital Expenditures |
(1.73) | (3.29) | (10.05) | (6.60) | (12.99) | (7.93) | (1.44) | 3.06 | 0.26 | (0.19) |
Net Current Asset Value |
(12.46) | 8.92 | 204.87 | 246.39 | 253.55 | 122.23 | 54.49 | 33.97 | (24.30) | (56.78) |
EV/EBIT |
0.00 | 0.00 | 5.42 | 5.59 | 17.61 | 52.15 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | (0.01) | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 9.79 | 8.40 | 27.57 | 53.96 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.13 | 0.16 | 0.27 | 0.22 | 0.39 | 0.58 | 0.86 | 0.73 | 0.80 |
Cash ROIC |
2.82% | 33.39% | 18.52% | 8.62% | 1.29% | (4.93%) | (14.83%) | 7.36% | (5.01%) | (5.85%) |
Accounts Receivable Turnover |
2.70 | 3.74 | 5.36 | 4.98 | 4.82 | 6.37 | 4.81 | 3.75 | 2.71 | 3.72 |
Accounts Payable Turnover |
2.05 | 2.55 | 2.99 | 2.82 | 2.67 | 3.07 | 3.55 | 5.03 | 2.54 | 2.42 |
Inventory Turnover |
5.66 | 7.10 | 7.23 | 6.28 | 4.96 | 4.06 | 2.81 | 2.24 | 1.59 | 2.47 |
Average Days of Payables |
149.41 | 166.22 | 143.54 | 168.02 | 139.64 | 97.24 | 49.90 | 52.24 | 165.91 | 184.59 |
Days of Inventory on Hand |
54.84 | 58.65 | 65.37 | 75.09 | 87.13 | 92.23 | 111.69 | 118.94 | 184.46 | 166.28 |
Average Receivables |
86.52 | 84.28 | 99.00 | 167.66 | 204.39 | 154.09 | 124.83 | 94.16 | 67.48 | 69.60 |
Average Payables |
93.73 | 93.78 | 131.78 | 221.02 | 293.17 | 252.88 | 136.46 | 51.74 | 44.18 | 65.92 |
Average Inventory |
34.03 | 33.65 | 54.43 | 99.44 | 157.49 | 191.32 | 172.11 | 116.53 | 70.84 | 64.77 |
Average Assets |
185.64 | 185.74 | 349.59 | 608.62 | 824.05 | 929.87 | 859.34 | 699.63 | 582.06 | 546.71 |
Average Common Equity |
19.60 | 19.80 | 149.13 | 310.97 | 388.59 | 439.38 | 424.80 | 371.01 | 302.74 | 233.63 |
Columns are period end dates